Home > Financial Ratios > PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH
Core EBITDA Growth

    Back to All Ratios
PROCTER & GAMBLE HEALTH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PROCTER & GAMBLE HEALTH
Please provide your vote to see the results

PROCTER & GAMBLE HEALTH Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Jun2024Mar2024Jun2023Jun2022
   Core EBITDA Growth(%) 2.21-6.25-6.2522.156.34

What is the latest Core EBITDA Growth ratio of PROCTER & GAMBLE HEALTH ?

The latest Core EBITDA Growth ratio of PROCTER & GAMBLE HEALTH is 2.21 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar20252.21
Jun2024-6.25
Mar2024-6.25
Jun202322.15
Jun20226.34

How is Core EBITDA Growth of PROCTER & GAMBLE HEALTH Trending?

Years Core EBITDA Growth % Change
Mar2025 2.21
Positive
Jun2024 -6.25
Negative
Mar2024 -6.25
Negative
Jun2023 22.15
249.37
Jun2022 6.34 -

Other Financial Ratios of PROCTER & GAMBLE HEALTH


Compare Core EBITDA Growth ratio of peers of PROCTER & GAMBLE HEALTH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PROCTER & GAMBLE HEALTH ₹9,772.3 Cr -0.9% -4.1% 4.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,419.0 Cr 3.5% 6.2% -4.2% Stock Analytics
DIVIS LABORATORIES ₹172,857.0 Cr -2.7% -0.7% 11% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,953.0 Cr 0.6% 9.1% 19.7% Stock Analytics
CIPLA ₹123,722.0 Cr 1.2% -1.4% -4.1% Stock Analytics
DR REDDYS LABORATORIES ₹103,906.0 Cr 3.9% 0.6% -3.7% Stock Analytics


PROCTER & GAMBLE HEALTH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PROCTER & GAMBLE HEALTH

-0.9%

-4.1%

4.3%

SENSEX

1.6%

2.7%

6.3%


You may also like the below Video Courses